Xencor (XNCR) Other Working Capital Changes (2017 - 2026)
Xencor (XNCR) posted quarterly Other Working Capital Changes of $2.4 million for Q1 2026, up 750.0% year-over-year from $281411.8 in Q1 2025, and up 116.27% quarter-over-quarter from $1.1 million in Q4 2025.
Analysis
Xencor (XNCR) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Xencor (XNCR) has reported Other Working Capital Changes for 9 consecutive years, with $2.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 750.0% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $9.9 million (up 2800.27% YoY), while the FY2025 annual figure was $7.2 million, changed N/A from the prior year.
- Other Working Capital Changes climbed to $2.4 million in Q1 2026 per XNCR's latest filing, from $1.1 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $6.9 million in Q2 2024 and bottomed at -$5.3 million in Q3 2025.
- Historically, Other Working Capital Changes has averaged -$774823.5 across 5 years, with a median of -$680000.0 in 2025.
- On a YoY basis, Other Working Capital Changes climbed as much as 1300.88% in 2023 and fell as far as 11666.67% in 2023.
- Xencor's Other Working Capital Changes stood at -$4.9 million in 2022, then tumbled by 89.52% to -$9.2 million in 2023, then soared by 36.1% to -$5.9 million in 2024, then surged by 118.77% to $1.1 million in 2025, then jumped by 116.27% to $2.4 million in 2026.
- Business Quant data shows XNCR's Other Working Capital Changes at $2.4 million in Q1 2026, $1.1 million in Q4 2025, and -$216000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Xencor | 2.02 Bn | 1.65 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.25 Mn |
| Jun 30, 2026 | 1.25 Mn |
| Mar 31, 2026 | 2.39 Mn |
| Mar 31, 2026 | 2.39 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | -216,000.00 |
| Sep 30, 2025 | -216,000.00 |
| Jun 30, 2025 | 6.66 Mn |
| Jun 30, 2025 | 6.66 Mn |
| Mar 31, 2025 | -368,000.00 |
| Mar 31, 2025 | -368,000.00 |
| Dec 31, 2024 | -5.89 Mn |
| Dec 31, 2024 | -5.89 Mn |
| Jun 30, 2024 | 5.89 Mn |
| Jun 30, 2024 | 5.89 Mn |
| Dec 31, 2023 | -9.22 Mn |
| Dec 31, 2023 | -9.22 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Sep 30, 2023 | 1.36 Mn |